Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Sensus Healthcare, Inc.

Get SEC filing alerts via email and in your feed for Sensus Healthcare, Inc.

SRTS

Sensus Healthcare, Inc.

About Sensus Healthcare, Inc.

Sensus Healthcare develops non-invasive, cost-effective superficial radiation therapy (SRT) devices for treating skin conditions like non-melanoma skin cancer and keloids. Its products serve dermatology and radiation oncology markets worldwide, offering safe, effective alternatives to surgery and traditional radiation. The company emphasizes proprietary technology, regulatory compliance, and global distribution, focusing on clinical outcomes, ease of use, and expanding aesthetic and medical applications.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Sensus Healthcare, Inc.

1
1
Sensus Healthcare, Inc. Sensus Healthcare Reports 59% Revenue Decline in Q1 2026

Via official filing (AI summary) | 22 days ago | 0 comments

2
1
Sensus Healthcare, Inc. Sensus Healthcare Reports 34% Revenue Decline and $7.7 Million Net Loss for Fiscal Year 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
Sensus Healthcare, Inc. Sensus Healthcare Reports 21.6% Revenue Decline and Net Loss in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Sensus Healthcare, Inc. Sensus Healthcare Reports 20.7% Revenue Decline in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Sensus Healthcare, Inc. Sensus Healthcare Reports 22.4% Revenue Decline and $2.6 Million Net Loss in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Sensus Healthcare, Inc. Sensus Healthcare Reports 71% Revenue Growth to $41.8 Million in 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
Sensus Healthcare, Inc. Sensus Healthcare Reports 125.6% Revenue Growth, Net Income Turnaround in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments